In the latest move in the legal battle between the two cannabis companies, Ascend Wellness (CSE:AAWH) (OTCQX:AAWH) filed an amended complaint against MedMen (CSE:MMEN) (OTCQX:MMNFF) for backing out of their acquisition contract and a motion to dismiss MedMen’s counterclaims.
Documents filed Monday state Ascend’s position that MedMen has a case of “seller’s remorse” and is using “fabricated allegations” in the hopes of undermining their contract in order to pursue a more lucrative deal with a new buyer. This, says Ascend Wellness, despite its legal obligation to Ascend after the company “provided millions of dollars to MedMen at their time of need,” according to a press statement from the multi-state, vertically integrated cannabis operator.
